MFDS — authorised 12 May 2023
- Marketing authorisation holder: ASTELLAS
- Status: likely_approved
MFDS authorised Veozah on 12 May 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 12 May 2023.
ASTELLAS holds the South Korean marketing authorisation.